About Dana Fowlkes
This author has not written his bio yet.
But we are proud to say that Dana Fowlkes contributed 57 entries already.
Entries by Dana Fowlkes
Lillian Chiang, CEO, presents at BioCentury Conference
Lillian Chiang, Evrys Bio’s CEO, presents at BioCentury’s East-West Biopharma Summit October 2-4 in Boston https://conferences.biocentury.com/east-west-summit
Lou Kassa, CEO of the Hepatitis B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center (PABC), talks with Dr. Lillian Chiang, CEO of Evrys Bio
Listen Here: https://www.buzzsprout.com/2098231/13449574
Main Menu
- Home
- Management, Board Members and Advisors
- Platform & Pipeline
- Platform and Pipeline
- An-allosteric-inhibitor-of-sirtuin-2-blocks-hepatitis-B-virus
- An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity
- Evrys SIRT2 Modulator Promotes Death of HCMV-Infected Monocytes, August 2023”.
- Evrys SIRT2 Allosteric Modulator with Broad-Spectrum Antiviral Activity, June 2023”.
- EvrysBio Science Update at BioCentury 2025 Chicago
- Structural basis for sirtuin 2 activity and modulation: Current state and opportunities
- News
- Contact Us
- Evrys Bio Slide Deck
- Jobs
Evrys Bio
3805 Old Easton Road
Doylestown, PA 18902
Federal Conflict of Interest Policy Statement
